4.6 Article

Design, Synthesis, and Apoptosis-Promoting Effect Evaluation of Rhopaladins' Analog 4-Arylidene-5-Oxopyrrolidine Derivatives

Journal

FRONTIERS IN CHEMISTRY
Volume 10, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fchem.2022.898436

Keywords

rhopaladins' analog; synthesis; 4-arylidene-5-oxopyrrolidine; cytotoxicity evaluation; anticancer; apoptosis

Funding

  1. National Natural Science Foundation of China [81872509]
  2. Baoan TCM Development Foundation [2020KJCX-KTYJ-200]
  3. Internal research project of Shenzhen Baoan Authentic TCM Therapy Hospital [BCZY2021003, BCZY2021007]
  4. Baoan District Medical and Health Basic Research Project [2020JD491]
  5. Chinese Medicine Research Fund of Health Commission of Hubei Province [ZY2021M038, ZY2021M051]
  6. Hubei Province Health and Family Planning Scientific Research Project [WJ2021M063, WJ2021M062]
  7. Open Project of Hubei Key Laboratory of Wudang Local Chinese Medicine Research (Hubei University of Medicine) [WDCM2020009]
  8. Scientific Research Project of Educational Commission of Hubei Province of China [B2020106]
  9. Sanming Project of Medicine in Shenzhen [SZZYSM202106004]

Ask authors/readers for more resources

Marine alkaloids have novel structures and antitumor activities. In this study, analogs of rhopaladins from marine alkaloids were synthesized and modified, leading to the discovery of RPDPRH with high efficiency and less hepatotoxicity. RPDPRH demonstrated potent in vitro anti-proliferative activity against various cancer cells, particularly in hepatocarcinoma cells. It induced apoptosis in these cells by regulating the expression of Bax and Bcl-2 proteins. These findings suggest that RPDPRH has the potential to be developed as an antitumor agent and warrants further investigation.
Marine alkaloids have novel structures and antitumor activities. Therefore, we synthesized rhopaladins' analogs from marine alkaloids rhopaladins A-D and modified their structures to synthesize 4-benzylidene-5-pyrrolidone derivatives. Among the compounds, (2E, 4E)-4-(4-chlorobenzylidene)-2-(4-chlorostyryl)-N-cyclohexyl-1-(4-fluorophenyl)-5-oxopyrrolidine-2-carboxamide (RPDPRH) has high efficiency and less hepatotoxicity, with IC50 values of 4.66, 6.42, 17.66, 15.2, 12.36, 22.4, and 243.2 mu M in vitro anti-proliferative activity testing against cervical cancer C-33A, CaSki, SiHa, and HeLa cells, human hepatocarcinoma HepG2 and 7402 cells, and human normal liver LO2 cells, respectively. In particular, RPDPRH has similar activity to cisplatin on human hepatocarcinoma cells, and cisplatin served as a positive control in our study. Next, the apoptosis of HepG2 and 7402 cells induced by RPDPRH at different concentrations was detected by Annexin V/PI flow cytometry. Moreover, the expression of apoptotic proteins was detected by Western blot analysis. Finally, the results showed that RPDPRH could induce apoptosis of hepatocarcinoma cells by regulating Bax and Bcl-2 expressions. In summary, our results indicate that RPDPRH has the potential to serve as an antitumor agent and plays a significant role in future studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available